A Study of PHN-010 in Patients With Advanced Solid Tumors
Pheon Therapeutics
Pheon Therapeutics
Tempus AI
Novartis
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
NextCure, Inc.
Elevation Oncology
NantCell, Inc.
Fusion Pharmaceuticals Inc.
SCRI Development Innovations, LLC
pharmaand GmbH
Fate Therapeutics
Novartis
National Institutes of Health Clinical Center (CC)
CureOne
Pfizer
Merck Sharp & Dohme LLC
Calando Pharmaceuticals
New Mexico Cancer Research Alliance
Case Comprehensive Cancer Center
Cancer Research UK
Vanderbilt-Ingram Cancer Center